| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2011 | WO2011045432A1 Improved medicinal aerosol formulations |
| 04/21/2011 | WO2011045429A1 Improved formulations |
| 04/21/2011 | WO2011045389A1 Silyl polymeric benzoic acid ester compounds, uses, and compositions thereof |
| 04/21/2011 | WO2011045353A1 Indole and azaindole modulators of the alpha 7 nachr |
| 04/21/2011 | WO2011045344A1 Pyrazolopyridine derivatives as anticancer agent |
| 04/21/2011 | WO2011045341A1 Ido inhibitors and therapeutic uses thereof |
| 04/21/2011 | WO2011045340A1 Ido inhibitors and therapeutic uses thereof |
| 04/21/2011 | WO2011045330A1 Macrocyclic integrase inhibitors |
| 04/21/2011 | WO2011045292A1 Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes |
| 04/21/2011 | WO2011045270A1 Monohydrate of pardoprunox |
| 04/21/2011 | WO2011045267A1 Polymorphs of pardoprunox |
| 04/21/2011 | WO2011045265A2 Spirocyclic derivatives as histone deacetylase inhibitors |
| 04/21/2011 | WO2011045258A1 Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor |
| 04/21/2011 | WO2011045257A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/21/2011 | WO2011045084A1 Quinolinyloxyphenylsulfonamides |
| 04/21/2011 | WO2011045075A1 Compositions comprising tramadol and celecoxib in the treatment of pain |
| 04/21/2011 | WO2011045068A2 Pharmaceutical composition containing cannabinoid-receptor antagonists |
| 04/21/2011 | WO2011045029A1 A composite comprising at least one type of perfluoroalkyl-perfluoro-phthalocyanine |
| 04/21/2011 | WO2011044978A1 Sulfoxide derivatives for treating tumors |
| 04/21/2011 | WO2011044962A1 Co-crystals of tramadol and coxibs |
| 04/21/2011 | WO2011044934A1 Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof |
| 04/21/2011 | WO2011044824A1 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treament of cancer thereof |
| 04/21/2011 | WO2011044751A1 Foliamangiferosides, preparation method and use thereof |
| 04/21/2011 | WO2011044746A1 Bamboo or wood vinegar solution, preparation method and use thereof |
| 04/21/2011 | WO2011044742A1 Medicaments for inhibiting thrombosis |
| 04/21/2011 | WO2011044737A1 Use of cyclophosphamide for treating condyloma acuminata |
| 04/21/2011 | WO2011026911A8 Bipyridines useful for the treatment of proliferative diseases |
| 04/21/2011 | WO2011025128A3 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor |
| 04/21/2011 | WO2011023954A3 Polymorphic forms of manidipine |
| 04/21/2011 | WO2011020030A9 Methods and compositions to prevent addiction |
| 04/21/2011 | WO2011018246A3 Controlled release paliperidone composition |
| 04/21/2011 | WO2011017137A3 Methods and compositions for treating insects |
| 04/21/2011 | WO2011015349A3 Methods for enhancing the cognitive function |
| 04/21/2011 | WO2011014973A3 Conformationally constrained, fully synthetic macrocyclic compounds |
| 04/21/2011 | WO2011014299A3 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2011009534A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 04/21/2011 | WO2011009533A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl derivatives, methods for the production thereof and use thereof for treating diseases |
| 04/21/2011 | WO2011009532A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases |
| 04/21/2011 | WO2011009059A3 Method of treating or preventing cancer |
| 04/21/2011 | WO2011008054A3 Butyric acid salt of n,n-dimethyl imidocarbon imidic diamide, method of preparing same, and pharmaceutical compositions and combinations containing same |
| 04/21/2011 | WO2011005593A3 Schistosomiasis vaccine compositions and methods of use |
| 04/21/2011 | WO2011004323A9 New inhibitors of proline racemase enzymes |
| 04/21/2011 | WO2011004175A3 Viscous topical antimicrobial compositions |
| 04/21/2011 | WO2011002184A3 Phosphoric acid ester of bicalutamide for treating prostate cancer |
| 04/21/2011 | WO2010151476A3 Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate |
| 04/21/2011 | WO2010150984A3 Amorphous adefovir dipivoxil solid dispersion with improved stability, and method for preparing same |
| 04/21/2011 | WO2010150281A3 Novel azabicyclohexanes |
| 04/21/2011 | WO2010149727A3 Injectable formulations containing asenapine and method of treatment using same |
| 04/21/2011 | WO2010148390A3 Polyamine transport inhibitors as novel therapeutics |
| 04/21/2011 | WO2010148179A8 Method of treating a disorder associated with mtp |
| 04/21/2011 | WO2010144742A3 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 04/21/2011 | WO2010144477A3 Sulfonylurea modulators of endothelin receptor |
| 04/21/2011 | WO2010141956A3 Methods and compositions for the treatment of cancer |
| 04/21/2011 | WO2010141949A3 Urea sorbent |
| 04/21/2011 | WO2010141842A3 Interlaced method for treating cancer or a precancerous condition |
| 04/21/2011 | WO2010141824A3 Use of targeted nitroxide agents in bone healing |
| 04/21/2011 | WO2010141810A3 Compositions and methods modulating mg29 for the treatment of diabetes |
| 04/21/2011 | WO2010141761A3 Polycyclic antagonists of lysophosphatidic acid receptors |
| 04/21/2011 | WO2010141712A9 Modulation of kcnq potassium channel activity for treatment of psychiatric disorders and the symptoms thereof |
| 04/21/2011 | WO2010141600A3 Improved method for synthesizing pirfenidone |
| 04/21/2011 | WO2010141584A3 Antagonism of human formyl peptide receptor for treatment of disease |
| 04/21/2011 | WO2010141511A3 Polynucleotides for multivalent rna interference, compositions and methods of use thereof |
| 04/21/2011 | WO2010141494A3 Synthesis of ezetimibe |
| 04/21/2011 | WO2010141471A3 Nucleic acid delivery compositions and methods of use thereof |
| 04/21/2011 | WO2010141406A3 Amino pyrimidine anticancer compounds |
| 04/21/2011 | WO2010138802A3 Compositions and their use for removing cholesterol |
| 04/21/2011 | WO2010137888A3 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same |
| 04/21/2011 | WO2010135662A3 Marker differentially expressed in cancer stem cells and methods of using same |
| 04/21/2011 | WO2010135527A3 Elastin for soft tissue augmentation |
| 04/21/2011 | WO2010135493A3 Alzheimer's disease imaging agents |
| 04/21/2011 | WO2010135452A3 Pyrazinamide for the treatment of leishmaniases |
| 04/21/2011 | WO2010135427A3 Trioxane monomers and dimers |
| 04/21/2011 | WO2010132502A3 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 04/21/2011 | WO2010129294A3 Small molecules supporting pluripotent cell growth and methods thereof |
| 04/21/2011 | WO2010124283A4 Methods and compositions relating to hematologic malignancies |
| 04/21/2011 | WO2010120750A3 Amorphous esomeprazole magnesium |
| 04/21/2011 | WO2010111525A9 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
| 04/21/2011 | WO2010105822A3 Dry processing of retigabine |
| 04/21/2011 | WO2010102071A8 Sustained release oral dosage forms of an r-baclofen prodrug |
| 04/21/2011 | WO2010067130A8 P38 map kinase inhibitors |
| 04/21/2011 | WO2010063030A3 Dermal application of vasoconstrictors |
| 04/21/2011 | WO2010059846A3 Sulfonamide inhibitors of carbonic anhydrase ii |
| 04/21/2011 | WO2010025859A3 Stabilization of cells by ionic liquids |
| 04/21/2011 | WO2010002835A3 Vinpocetine and eburnamonine derivatives for promoting bone growth |
| 04/21/2011 | WO2009155585A8 Dna-directed customization of analgesic compounds as a therapeutic modality |
| 04/21/2011 | WO2008104893A3 Nucleoside derivatives useful for the treatment or prevention of viral infections and methods of use thereof |
| 04/21/2011 | WO2008090474A3 Production of rosmarinic acid from spearmint and uses thereof |
| 04/21/2011 | WO2008087558A3 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 04/21/2011 | WO2008080988A3 Cyclopentanone derivatives, method of synthesis and uses thereof |
| 04/21/2011 | US20110092926 Abuse potential reduction in abusable substance dosage form |
| 04/21/2011 | US20110092733 Nateglinide crystals |
| 04/21/2011 | US20110092729 Process of hydrocyanation of unsaturated carboxylic acid derivatives |
| 04/21/2011 | US20110092704 Preparation of triazospiro compounds |
| 04/21/2011 | US20110092694 Synthesis of 5-azacytidine |
| 04/21/2011 | US20110092603 Composition to enhance the bioavailability of curcumin |
| 04/21/2011 | US20110092602 Rapidly disintegrating oral compositions of tramadol |
| 04/21/2011 | US20110092601 Lysine-specific demethylase inhibitors |
| 04/21/2011 | US20110092600 Pharmaceutical compositions comprising aminocyclohexane derivatives |
| 04/21/2011 | US20110092599 Use of Treprostinil to treat neuropathic diabetic foot ulcers |